<PubmedArticle>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25161267</PMID>
<DateCompleted>
<Year>2015</Year>
<Month>03</Month>
<Day>03</Day>
</DateCompleted>
<DateRevised>
<Year>2014</Year>
<Month>10</Month>
<Day>10</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1528-0020</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>124</Volume>
<Issue>15</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
<Day>09</Day>
</PubDate>
</JournalIssue>
<Title>Blood</Title>
<ISOAbbreviation>Blood</ISOAbbreviation>
</Journal>
<ArticleTitle>Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis.</ArticleTitle>
<Pagination>
<MedlinePgn>2354-61</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1182/blood-2014-05-578963</ELocationID>
<Abstract>
<AbstractText>Patients with double-hit lymphoma (DHL), which is characterized by rearrangements of MYC and either BCL2 or BCL6, face poor prognoses. We conducted a retrospective multicenter study of the impact of baseline clinical factors, induction therapy, and stem cell transplant (SCT) on the outcomes of 311 patients with previously untreated DHL. At median follow-up of 23 months, the median progression-free survival (PFS) and overall survival (OS) rates among all patients were 10.9 and 21.9 months, respectively. Forty percent of patients remain disease-free and 49% remain alive at 2 years. Intensive induction was associated with improved PFS, but not OS, and SCT was not associated with improved OS among patients achieving first complete remission (P = .14). By multivariate analysis, advanced stage, central nervous system involvement, leukocytosis, and LDH &gt;3 times the upper limit of normal were associated with higher risk of death. Correcting for these, intensive induction was associated with improved OS. We developed a novel risk score for DHL, which divides patients into high-, intermediate-, and low-risk groups. In conclusion, a subset of DHL patients may be cured, and some patients may benefit from intensive induction. Further investigations into the roles of SCT and novel agents are needed. </AbstractText>
<CopyrightInformation>Â© 2014 by The American Society of Hematology.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Petrich</LastName>
<ForeName>Adam M</ForeName>
<Initials>AM</Initials>
<AffiliationInfo>
<Affiliation>Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL;</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gandhi</LastName>
<ForeName>Mitul</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL;</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jovanovic</LastName>
<ForeName>Borko</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL;</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Castillo</LastName>
<ForeName>Jorge J</ForeName>
<Initials>JJ</Initials>
<AffiliationInfo>
<Affiliation>Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA;</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rajguru</LastName>
<ForeName>Saurabh</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Division of Hematology/Oncology and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yang</LastName>
<ForeName>David T</ForeName>
<Initials>DT</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, WI;</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shah</LastName>
<ForeName>Khushboo A</ForeName>
<Initials>KA</Initials>
<AffiliationInfo>
<Affiliation>Hematology/Oncology, Dartmouth-Hitchcock Medical Center, Lebanon, NH;</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Whyman</LastName>
<ForeName>Jeremy D</ForeName>
<Initials>JD</Initials>
<AffiliationInfo>
<Affiliation>Hematology/Oncology, Dartmouth-Hitchcock Medical Center, Lebanon, NH;</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lansigan</LastName>
<ForeName>Frederick</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Hematology/Oncology, Dartmouth-Hitchcock Medical Center, Lebanon, NH;</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hernandez-Ilizaliturri</LastName>
<ForeName>Francisco J</ForeName>
<Initials>FJ</Initials>
<AffiliationInfo>
<Affiliation>Departments of Immunology and Medicine, Roswell Park Cancer Institute, Buffalo, NY;</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lee</LastName>
<ForeName>Lisa X</ForeName>
<Initials>LX</Initials>
<AffiliationInfo>
<Affiliation>Department of Oncology, Albert-Einstein Cancer Center-Montefiore Medical Center, Bronx, NY;</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Barta</LastName>
<ForeName>Stefan K</ForeName>
<Initials>SK</Initials>
<AffiliationInfo>
<Affiliation>Department of Oncology, Albert-Einstein Cancer Center-Montefiore Medical Center, Bronx, NY;</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Melinamani</LastName>
<ForeName>Shruthi</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Hematology &amp; Oncology, Rush University Medical Center, Chicago, IL;</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Karmali</LastName>
<ForeName>Reem</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Hematology &amp; Oncology, Rush University Medical Center, Chicago, IL;</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Adeimy</LastName>
<ForeName>Camille</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Cardinal Bernardin Cancer Center, Loyola University Medical Center, Maywood, IL;</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Smith</LastName>
<ForeName>Scott</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Cardinal Bernardin Cancer Center, Loyola University Medical Center, Maywood, IL;</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dalal</LastName>
<ForeName>Neil</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Division of Hematology/Oncology, Advocate Lutheran General Hospital, Park Ridge, IL;</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nabhan</LastName>
<ForeName>Chadi</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Section of Hematology and Oncology, Department of Medicine, The University of Chicago, Chicago, IL;</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Peace</LastName>
<ForeName>David</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, Section of Hematology-Oncology, University of Illinois at Chicago, Chicago, IL;</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Vose</LastName>
<ForeName>Julie</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Hematology/Oncology, University of Nebraska Medical Center, Omaha, NE;</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Evens</LastName>
<ForeName>Andrew M</ForeName>
<Initials>AM</Initials>
<AffiliationInfo>
<Affiliation>Division of Hematology/Oncology, Tufts Medical Center and Tufts University School of Medicine, Boston, MA;</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shah</LastName>
<ForeName>Namrata</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Division of Hematology &amp; Oncology, Medical College of Wisconsin, Milwaukee, WI;</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fenske</LastName>
<ForeName>Timothy S</ForeName>
<Initials>TS</Initials>
<AffiliationInfo>
<Affiliation>Division of Hematology &amp; Oncology, Medical College of Wisconsin, Milwaukee, WI;</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zelenetz</LastName>
<ForeName>Andrew D</ForeName>
<Initials>AD</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY;</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Landsburg</LastName>
<ForeName>Daniel J</ForeName>
<Initials>DJ</Initials>
<AffiliationInfo>
<Affiliation>Division of Hematology/Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA;</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Howlett</LastName>
<ForeName>Christina</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Division of Hematology/Oncology, Hackensack University Medical Center, Hackensack, NJ; Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ;</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mato</LastName>
<ForeName>Anthony</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Division of Hematology/Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA; Division of Hematology/Oncology, Hackensack University Medical Center, Hackensack, NJ;</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jaglal</LastName>
<ForeName>Michael</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL;</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chavez</LastName>
<ForeName>Julio C</ForeName>
<Initials>JC</Initials>
<AffiliationInfo>
<Affiliation>Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL;</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tsai</LastName>
<ForeName>Judy P</ForeName>
<Initials>JP</Initials>
<AffiliationInfo>
<Affiliation>Division of Hematology/Oncology and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Reddy</LastName>
<ForeName>Nishitha</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Division of Hematology/Oncology and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Li</LastName>
<ForeName>Shaoying</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN;</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Handler</LastName>
<ForeName>Caitlin</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA;</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Flowers</LastName>
<ForeName>Christopher R</ForeName>
<Initials>CR</Initials>
<AffiliationInfo>
<Affiliation>Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA;</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cohen</LastName>
<ForeName>Jonathon B</ForeName>
<Initials>JB</Initials>
<AffiliationInfo>
<Affiliation>Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA; Division of Hematology, The Ohio State University-James Comprehensive Cancer Center, Columbus, OH;</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Blum</LastName>
<ForeName>Kristie A</ForeName>
<Initials>KA</Initials>
<AffiliationInfo>
<Affiliation>Division of Hematology, The Ohio State University-James Comprehensive Cancer Center, Columbus, OH;</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Song</LastName>
<ForeName>Kevin</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Leukemia/BMT Program of British Columbia, British Columbia Cancer Agency, Vancouver, BC, Canada;</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sun</LastName>
<ForeName>Haowei Linda</ForeName>
<Initials>HL</Initials>
<AffiliationInfo>
<Affiliation>Leukemia/BMT Program of British Columbia, British Columbia Cancer Agency, Vancouver, BC, Canada;</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Press</LastName>
<ForeName>Oliver</ForeName>
<Initials>O</Initials>
<AffiliationInfo>
<Affiliation>Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA;</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cassaday</LastName>
<ForeName>Ryan</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA;</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jaso</LastName>
<ForeName>Jesse</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology, MD Anderson Cancer Center, Houston, TX; and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Medeiros</LastName>
<ForeName>L Jeffrey</ForeName>
<Initials>LJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology, MD Anderson Cancer Center, Houston, TX; and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sohani</LastName>
<ForeName>Aliyah R</ForeName>
<Initials>AR</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Abramson</LastName>
<ForeName>Jeremy S</ForeName>
<Initials>JS</Initials>
<AffiliationInfo>
<Affiliation>Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016448">Multicenter Study</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>08</Month>
<Day>26</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Blood</MedlineTA>
<NlmUniqueID>7603509</NlmUniqueID>
<ISSNLinking>0006-4971</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000369">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018572">Disease-Free Survival</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D053208">Kaplan-Meier Estimate</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008223">Lymphoma</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015999">Multivariate Analysis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012074">Remission Induction</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012189">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D033581">Stem Cell Transplantation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2014</Year>
<Month>8</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2014</Year>
<Month>8</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2015</Year>
<Month>3</Month>
<Day>4</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">25161267</ArticleId>
<ArticleId IdType="pii">blood-2014-05-578963</ArticleId>
<ArticleId IdType="doi">10.1182/blood-2014-05-578963</ArticleId>
</ArticleIdList>
</PubmedData>
</PubmedArticle>